IUBio GIL .. BIOSCI/Bionet News .. Biosequences .. Software .. FTP

<html>

<head>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">


<meta name=Generator content="Microsoft Word 10 (filtered)">

<style>
<!--
 /* Font Definitions */
 @font-face
        {font-family:Verdana;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman";}
a:link, span.MsoHyperlink
        {color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {color:purple;
        text-decoration:underline;}
span.EmailStyle17
        {font-family:Verdana;
        color:windowtext;
        font-weight:normal;
        font-style:normal;
        text-decoration:none none;}
@page Section1
        {size:8.5in 11.0in;
        margin:1.0in 1.25in 1.0in 1.25in;}
div.Section1
        {page:Section1;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple>

<div class=Section1>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Hi,</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Please consider posting this webinar about metabolomics.
Thank you for your consideration.</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Joan Boyce</span></font></p>

<p class=MsoNormal><i><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana;font-style:italic'>Genetic Engineering &amp; Biotechnology
News</span></font></i></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Metabolomics Webinar: Analytics, Tools, and Applications</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Date: </span></font><font
 size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>August
 28, 2008</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Time: </span></font><font size=2 face=Verdana><span
 style='font-size:10.0pt;font-family:Verdana'>1:00 pm </span></font><font
  size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>EDT</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Register for free at [url=null]www.genengnews.com/metabolomics[/url]</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Metabolomics&#8212;the small molecule chemical footprint
of biological processes&#8212;is poised to take its rightful place beside
genomics and proteomics as an enabling biotechnique. Scientists involved in the
discovery and clinical development of new drugs should attend this free webinar
to learn how this technique can advance research.</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Key learning points for this webinar:</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>*Examples of metabolomes and where they fit into the
larger biological picture </span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>*Analytical techniques for uncovering and exploiting metabolomics&#8212;capabilities
and limitations </span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>*Implications of metabolomics for biomedicine, drug
discovery, and development </span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>*Metabolomics case studies in diabetes and prostate cancer
</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Your hosts for this webinar, [b]Chris Beecher, Ph.D[/b]. (</span></font><font
  size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>University</span></font><font
 size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'> of </span></font><font
  size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>Michigan</span></font><font
size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>), and
[b]Chris Newgard, Ph.D[/b]. (</span></font><font size=2 face=Verdana><span
  style='font-size:10.0pt;font-family:Verdana'>Duke</span></font><font size=2
 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'> </span></font><font
  size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>University</span></font><font
size=2 face=Verdana><span style='font-size:10.0pt;font-family:Verdana'>), [b]Steven
Fischer, Ph.D.[/b] (Agilent Technologies), bring years of combined experience
surrounding metabolomics. They will present specific examples of how metabolomics
can be applied to translational medicine, diabetes, and prostate cancer.</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>A live Q&amp;A session will follow the presentations,
offering you a chance to pose questions to our expert panelists.</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>Produced by [i]Genetic Engineering &amp; Biotechnology
News[/i][/font][/size][/size]</span></font></p>

<p class=MsoNormal><font size=2 face=Verdana><span style='font-size:10.0pt;
font-family:Verdana'>&nbsp;</span></font></p>

<p class=MsoNormal><font size=3 face="Times New Roman"><span style='font-size:
12.0pt'>&nbsp;</span></font></p>

</div>

</body>

</html>

Send comments to us at archive@iubio.bio.indiana.edu